BridgeMD
New treatment option for Different Methods to Minimize Blood Loss During Laparoscopic Myomectomy
Official title Different Methods to Minimize Blood Loss During Laparoscopic Myomectomy; A Randomized Controlled Clinical Trial
ClinicalTrials.gov ID: NCT06566352
What this study is testing
What is injection of epinephrine 1mg diluted in 200mg of NaCl?
injection of epinephrine 1mg diluted in 200mg of NaCl is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for different methods to minimize blood loss during laparoscopic myomectomy.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Laparoscopic myomectomy with temporary bilateral uterine artery occlusion or intramyometrial injection of diluted epinephrine will be important to reduce intraoperative bleeding, time of operation and hospitalization period after laparoscopic myomectomy.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 39, women only
You may be able to join if
- Women aged from 18 to 39 years.
- Symptomatizing Women (heavy menstrual bleeding or subfertility).
- FIGO stage (3-7) by ultrasound.
- Only uterine corpus fibroid.
- Up to three fibroids by ultrasound.
You likely can't join if
- Patients with bleeding tendency.
- Patients who refuse to participate in the study or uncooperative patients.
- Current pregnancy.
- Any retroperitoneal surgery at pararectal space.
- More than one cesarean delivery.
See the full eligibility criteria
- Women aged from 18 to 39 years.
- Symptomatizing Women (heavy menstrual bleeding or subfertility).
- FIGO stage (3-7) by ultrasound.
- Only uterine corpus fibroid.
- Up to three fibroids by ultrasound.
- No previous hormonal treatment.
- Patients with bleeding tendency.
- Patients who refuse to participate in the study or uncooperative patients.
- Current pregnancy.
- Any retroperitoneal surgery at pararectal space.
- More than one cesarean delivery.
The study team makes the final eligibility decision.
Where it's taking place
- Zagazig, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 39 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zagazig, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.